Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Diabetes Care 2013;36:3620e6
A dedicated sharps container keeps everyone safe and is legally required in most jurisdictions
Villani et al
The following GLP-1RAs showed a significantly higher odds ratio of discontinuation due to adverse events compared with placebo: lixisenatide (odds ratio 2.86 (95% confidence interval 1.48 to 5.51)), semaglutide (2.61 (1.56 to 4.37)), exenatide (2.39 (1.14 to 4.98)), tirzepatide (2.30 (1.30 to 4.09)), and liraglutide (2.15 (1.26 to 3.69)) (fig 8A)
Lancet 2016;387:67990.ArticlePubMed 21
Injection site management Early dosing does not directly affect injection site reactions, but it is worth noting that rotating injection sites remains important regardless of timing
